The Pulmonary Hypertension Association will offer a free, regional workshop for people affected by pulmonary hypertension in Charlotte, North Carolina on Saturday, March 22. The PHA Connects: PH ...

Finding it hard to breathe when you lay down is medically called orthopnea. Find a list of potential causes to help narrow ...

Eko Health has been advancing the use of artificial intelligence to help providers detect the early signs of disease, ...

According to the NHS, atherosclerosis occurs when arteries become narrowed, making it difficult for blood to flow through ...

Merck plans to stop a late-stage study testing its drug to treat pulmonary arterial hypertension (PAH) ahead of time based on ...

Merck to stop phase 3 HYPERION trial evaluating Winrevair early and move to final analysis: Rahway, New Jersey Friday, January 31, 2025, 10:00 Hrs [IST] Merck, known as MSD outsid ...

A 41-year-old man was evaluated for swelling in the ankles and syncope. CT of the chest showed bilateral mediastinal and ...

Clinical worsening events are defined as all-cause death, non-planned PAH worsening-related ... 60 mg WINREVAIR is FDA-approved for the treatment of adults with pulmonary arterial hypertension (PAH, ...

Merck , known as MSD outside of the United States and Canada, announced today the Phase 3 HYPERION study evaluating WINREVAIR (sotatercept-csrk) versus placebo (both in combination with background ...

Taking place on February 14-16, 2025, in Washington, the American College of Cardiology (ACC) Advancing the Cardiovascular Care of the Oncology Patient conference is an interdisciplinary and ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

Tectonic Therapeutic said the findings support the design and population for Phase 2 APEX trial, which will test TX45 in ...